Sorted By:

Relevance


PhRMA Statement on Orphan Diseases

PhRMA  |  Press Release

“The illnesses being targeted include rare cancers, autoimmune disorders, cardiovascular disorders, and more.
https://www.phrma.org/press-release/phrma-statement-on-orphan-diseases

Biopharmaceutical industry has made progress in cancer fight, continues work toward moonshot

PhRMA  |  Blog Post

The cancer death rate has declined 23 percent since its peak in 1991, in large part due to medicines, and the chances a cancer patient will live five years or more has increased by 39 percent across all cancers.
http://catalyst.phrma.org/biopharmaceutical-industry-has-made-progress-in-cancer-fight-continues-work-toward-moonshot

PhRMA Honors Research & Hope Award Recipients

PhRMA  |  Blog Post

Liz and Jay Scott, co-executive directors, Alex’s Lemonade Stand Foundation , honored for efforts to raise awareness and research funding for childhood cancers .youtube.com/embed/videoseries?
http://catalyst.phrma.org/phrma-honors-research-hope-award-recipients

The Cost of Innovation

PhRMA  |  Blog Post

A recent report on the so-called “failure” rates for three difficult-to-treat cancers – melanoma, lung cancer, and brain cancer – illustrates just how difficult the clinical trial process can be.
http://catalyst.phrma.org/the-cost-of-innovation

PhRMA Names Charles Clapton, Senior Vice President, Federal Advocacy

PhRMA  |  Press Release

“Chuck’s experience, reputation, and results-oriented focus during his distinguished career on Capitol Hill will be tremendous assets to PhRMA and its members as he leads our Federal Advocacy efforts” said Davis. 
https://www.phrma.org/press-release/phrma-names-charles-clapton-senior-vice-president-federal-advocacy

Uchechi T.

From Hope To Cures  |  From Our Network

I now have a career in the cancer research field, and spend my days promoting health and wellness, while educating people on the importance of cancer research.
http://www.fromhopetocures.org/imnotaverage/uchechi-t

Deborah Goldstein

From Hope To Cures  |  From Our Network

 I worked and built a career as a Trade Show Marketing professional.
http://www.fromhopetocures.org/imnotaverage/deborah-g

Glenn J. Gormley, MD, PhD

PhRMA  |  Biography

Early in his career, Dr.
https://www.phrma.org/biography/glenn-j-gormley-md-phd

2015: A banner year for personalized medicine

PhRMA  |  Blog Post

Personalized medicine is an emerging field of medicine that uses diagnostic tools to identify specific biological markers to help assess which medical treatments and procedures will be best for each patient.
http://catalyst.phrma.org/2015-a-banner-year-for-personalized-medicine

From Hope to Cures: The Value of Biopharmaceutical Innovation

PhRMA  |  Blog Post

Biopharmaceutical companies create medicines that provide patients with hope and new treatments are increasing survival rates and raising cure rates for various cancers and other diseases.
http://catalyst.phrma.org/from-hope-to-cures-the-value-of-biopharmaceutical-innovation

Debunking Common Myths About Clinical Trials

PhRMA  |  Blog Post

Many health insurance carriers will cover patient care costs, but you should ask the clinical trial research team which costs will be your responsibility and also check with your health insurance carrier about the coverage they provide for clinical trial participants before making the decision about participating in a clinical trial. 
http://catalyst.phrma.org/debunking-common-myths-about-clinical-trials

Cancer treatments got gentler, yet kids’ survival improved

From Hope To Cures  |  From Our Network

And fewer kids died from second cancers or heart or lung problems 15 years after their initial treatment ended.
http://www.fromhopetocures.org/cancer-treatments-got-gentler-yet-kids-survival-improved

Scientific Progress Spurs Research Into Record Number of Cancer Medicines

PhRMA  |  Press Release

Neil added, “We are hopefully moving to the beginning of the end for many cancers.”
https://www.phrma.org/press-release/scientific-progress-spurs-research-into-record-number-of-cancer-medicines

PhRMA Statement on Surgeon General Nominee

PhRMA  |  Press Release

Benjamin has been aggressive throughout her career in advocating prevention of illness and in working to eliminate troubling disparities in health care access, quality and outcomes.
https://www.phrma.org/press-release/phrma-statement-on-surgeon-general-nominee

Scott Olsen to Lead Federal Advocacy at PhRMA

PhRMA  |  Press Release

He began his career working in the office of then-Senator Max Baucus (D-MT).
https://www.phrma.org/press-release/scott-olsen-to-lead-federal-advocacy-at-phrma

Amy Comstock Rick

PhRMA  |  Biography

Rick began her professional career at the law firm of Beveridge & Diamond.
https://www.phrma.org/biography/amy-comstock-rick

Meet the Chart Pack

PhRMA  |  Blog Post

 Page 7 shows the decline in death rates from cancer from 1975 to 2006, due in no small part to medical advances.
http://catalyst.phrma.org/meet-the-chart-pack

High Cost of Medicines in Health Insurance Exchange Plans Is Harming Patients

PhRMA  |  Blog Post

The study also finds that more than 60 percent of Silver plans place all covered medications for multiple sclerosis, rheumatoid arthritis, Crohn’s disease and certain cancers in the plan’s highest formulary tier.
http://catalyst.phrma.org/high-cost-of-medicines-in-health-insurance-exchange-plans-is-harming-patients

Seizing the opportunity to rebuild U.S. leadership in STEM

PhRMA  |  Blog Post

And for low-income students, the survey shows that most are unaware of potential STEM career opportunities and have the least access to those who work in these fields.
http://catalyst.phrma.org/seizing-the-opportunity-to-re-build-u.s.-leadership-in-stem

Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts

PhRMA  |  Press Release

“We are entering an era of medical innovation that offers a real chance to find therapies for some of the most challenging diseases, from Alzheimer’s, to ALS, to many of the cancers that now have few or no treatments.
https://www.phrma.org/press-release/pfizer-s-ian-read-becomes-phrma-board-chairman-ken-frazier-george-scangos-assume-new-posts

PhRMA Statement on 2013 Special 301 Report

PhRMA  |  Press Release

The Special 301 process garners high-level attention from our trading partners -- attention that is needed to redress intellectual property violations and market access concerns within individual markets and to send signals to other U.S. trading partners that protecting American intellectual property is important to the U.S. economy.
https://www.phrma.org/press-release/phrma-statement-on-2013-special-301-report

PhRMA President and CEO Tauzin Decides To End Tenure in June; Search for Successor Begins

PhRMA  |  Press Release

We wish him the best as he turns the page on another successful chapter in his career.
https://www.phrma.org/press-release/phrma-president-and-ceo-tauzin-decides-to-end-tenure-in-june-search-for-successor-begins

James M. "Mit" Spears Named Executive Vice President & General Counsel

PhRMA  |  Press Release

His career began as the Staff Assistant to Governor William P.
https://www.phrma.org/press-release/james-m-mit-spears-named-executive-vice-president-and-general-counsel

Paving the Way for Better Cancer Treatments

PhRMA  |  Blog Post

Researchers are developing new weapons to fight the collection of diseases known as cancer, and discovering new ways to use existing therapies, either alone or in combination with other therapies, to treat various cancers.
http://catalyst.phrma.org/paving-the-way-for-better-cancer-treatments

New prostate cancer treatment will get its first test in Omaha

From Hope To Cures  |  From Our Network

He is a medical oncologist specializing in treatment of prostate, bladder, kidney and testicular cancers.
http://www.fromhopetocures.org/new-prostate-cancer-treatment-will-get-its-first-test-in-omaha

You have reviewed the first 200 results out of 263. Each page contains 25 results. You're on page 8.

prev 7 8 9 10 11 next